Clinical trials
Expanded access Sarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Available | 6 |
| No longer available | 6 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epizyme, Inc. | 2 |
| AVM Biotechnology Inc | 1 |
| Advenchen Laboratories, LLC | 1 |
| Agenus Inc. | 1 |
| Aveni Foundation | 1 |
| CytRx | 1 |
| Eli Lilly and Company | 1 |
| Janssen Research & Development, LLC | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 13 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Chondrosarcoma | 2 |
| Neoplasms | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.